Morris & Dickson’s Controlled Substance License Revoked
Recently, the United States Drug Enforcement Administration (DEA) announced that, barring a settlement, it will revoke Morris…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
July 2023
Will Insulin Pricing Change the Pharmaceutical Industry?
Recently, Dr. Robert Popovian, Erin Delaney, and Dr. Michael Mandel published an editorial for the Progressive Policy Institute,…
Senate Finance Committee Releases Framework for PBM Solutions
Recently, Senate Finance Committee Chair Ron Wyden and Ranking Member Mike Crapo issued a bipartisan framework that outlines the…
HIPAA Enforcement Discretion Ends as Part of COVID Public Health Emergency…
As with many other things, the Notifications of Enforcement Discretion issued during the COVID-19 public health emergency by the…
Bipartisan Senators Call for Action on Post-Fracture Osteoporosis Care
Recently, a bipartisan group of United States Senators sent a letter to Shalanda Young, the director of the Office of Management…
The Rise of Social Media Influencers in Pharmaceutical Industry Marketing
University of Colorado Boulder recently published a report that sought to understand the way patient influencers communicate…
FDA Issues Draft Guidance on Decentralized Clinical Trials
Recently, the United States Food and Drug Administration (FDA) issued a Draft Guidance, “Decentralized Clinical Trials for Drugs,…
OPDP Untitled Letters Are Back
The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently sent its first untitled…
Transparency, Aggregate Spend & HCP Engagement 2023
Transparency, Aggregate Spend & HCP Engagement is the leading event for life science companies to keep up to date on current…
PatientView Releases 2022 Patient Group Survey on Pharmaceutical Industry
Recently, PatientView released its Corporate Reputation of Pharma survey results, which found that more than half of patient…